Patent · US Expired

Treatment of gastrointestinal stromal tumors

US6958335B2 · kind B2 · utility

16Cited by

0References

6Claims

0Family size

Assignees

Inventors

Elisabeth Buchdunger · Neuenbürg, DE
Renaud Capdeville · Riedisheim, FR
George D. Demetri · Brookline, US
Sasa Dimitrijevic · Habsheim, FR
Brian J. Druker · Portland, US
Jonathan A. Fletcher · Brookline, US
Michael Heinrich · Lake Oswego, US
Heikki Joensuu · Espoo, FI
Sandra Leta Silberman · Dover, US
David A. Tuveson · Berwyn, US

Key dates

Filing date	Oct 26, 2001
Grant date	Oct 25, 2005
Priority date	—
Expiry date	Dec 18, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.